Why it matters: This deal is one step closer to consolidating the big health insurers and the big pharmacy benefit managers under the same roof. The companies say that will save consumers money on prescription drugs, though some policy analysts and researchers are skeptical.
Inside the White House with D.C.'s most wired reporter. Sign up for Mike Allen's Axios AM.
More stories loading.